TrialBlood advances2026

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

Riccardo Moia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.